Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60044, USA. irini.zanze.@abbott.com
Abstract:
We report the discovery of a novel class of glucocorticoid receptor (GR) antagonists based on the chromene molecular scaffold. The compounds exhibit good functional potency and an improved receptor selectivity profile for GR over other steroid receptors when compared to the classical steroidal GR-antagonist, RU-486.